MedTrace Logo

Zinc for the Treatment of Herpes Simplex Labialis (HSL)

NCT00809809 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 157

Last updated 2014-01-08

Study results available
· View outcomes & findings →

Summary

Evaluate the effectiveness of a topical preparation of zinc to treat cold sores.

Conditions

  • Herpes Simplex Labialis

Interventions

DRUG

Zicam (Ionic zinc)

33mmol/l of ionic zinc

DRUG

placebo

placebo swab

Sponsors & Collaborators

  • Women's Health Services, Santa Fe, New Mexico

    collaborator OTHER

  • Southwest College of Naturopathic Medicine

    collaborator OTHER

  • Beth Israel Medical Center

    collaborator OTHER

  • Matrixx Initiatives, Inc.

    collaborator INDUSTRY

  • Integrative Medicine Institute

    lead OTHER

Principal Investigators

  • David S Riley, MD · University of New Mexico

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-09-30
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00809809 on ClinicalTrials.gov